BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Transl Med. Nov 28, 2026; 12(4): 124522
Published online Nov 28, 2026. doi: 10.5528/wjtm.124522
Fatal hemorrhagic transformation after ischemic stroke in a child with sickle cell disease SS: A case report
Sêtondji Emmanuel Raymond Ahouangansi, Adelin Ouohi, Loes Koffi, Affoua Mouroufié Kossonou, Koffi Isidore Kouamé, Walamitien Cyrille Toure, Yao Vianney Bédié, Koffi Manassé Kakou, Etienne Spah N’dah, Kadidja Koné, Stéphane Charles Evrard Adingra, Konaté Aboudramane, Yikpé Denis Ayé
Sêtondji Emmanuel Raymond Ahouangansi, Adelin Ouohi, Loes Koffi, Affoua Mouroufié Kossonou, Koffi Isidore Kouamé, Walamitien Cyrille Toure, Yao Vianney Bédié, Koffi Manassé Kakou, Etienne Spah N’dah, Kadidja Koné, Stéphane Charles Evrard Adingra, Konaté Aboudramane, Yikpé Denis Ayé, Department of Anesthesiology and Critical Care, Faculty of Medical Sciences, Félix Houphouët-Boigny University, Abidjan 01 BP V 34, 01, Côte d’Ivoire
Author contributions: Ahouangansi SER contributed to the study concept, clinical management, data collection, manuscript drafting, and final approval of the manuscript; Ahouangansi SER, Ouohi A, Koffi L, Kossonou AM, Kouamé KI, Toure WC, Bédié YV, Kakou KM, N’dah ES, Koné K, Adingra SCE, Aboudramane K, and Ayé YD contributed to data collection, clinical management, critical review, and final approval of the manuscript.
AI contribution statement: The authors take full responsibility and accountability for all content of this manuscript, including any portions for which AI tools were used as assistive technologies. All AI-assisted outputs were carefully reviewed, validated, and approved by the authors. AI tools were not used to generate original scientific data, perform independent scientific analyses, or draw scientific conclusions.
Informed consent statement: Written informed consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: All authors declare no conflicts of interest related to this publication.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Sêtondji Emmanuel Raymond Ahouangansi, MD, Assistant Chief of Clinic, Department of Anesthesiology and Critical Care, Faculty of Medical Sciences, Félix Houphouët-Boigny University, Abidjan 01 BP V 34, 01, Côte d’Ivoire. aemmaray15@gmail.com
Received: June 18, 2026
Revised: August 12, 2026
Accepted: October 10, 2026
Published online: November 28, 2026
Processing time: 140 Days and 5.4 Hours
Abstract
BACKGROUND

Sickle cell disease homozygous SS (SCD-SS) is the most prevalent hemoglobinopathy in sub-Saharan Africa, accounting for nearly 80% of global cases. Ischemic stroke affects approximately 11% of children with the SS genotype before the age of 20 years, while hemorrhagic stroke carries a significantly higher case fatality rate. The sequential occurrence of both stroke subtypes in a single pediatric patient, in the context of Plasmodium falciparum malaria and absence of secondary prevention, represents an exceptionally rare and clinically alarming event.

CASE SUMMARY

We report an 8-year-old girl with SCD-SS and a history of ischemic stroke resulting in left hemiplegia, for whom no structured secondary stroke prevention had been implemented. She was admitted to the intensive care unit for impaired consciousness, generalized tonic-clonic seizures, and high-grade fever in the setting of active Plasmodium falciparum malaria. On admission, her Glasgow Coma Scale score was 11/15, and laboratory investigations revealed severe anemia (hemoglobin level 7.6 g/dL). Initial cerebral computed tomography (CT) demonstrated a subacute ischemic infarction involving the right anterior and middle cerebral artery territories. Management included intravenous artesunate, anticonvulsants, packed red blood cell transfusions, and dexamethasone. On day 4, her Glasgow Coma Scale score dropped to 5/15, with anisocoria and meningeal signs. Emergency CT revealed diffuse subarachnoid hemorrhage, cerebral edema, and an 8-mm subfalcine herniation, consistent with hemorrhagic transformation. The patient died on day 5.

CONCLUSION

The absence of secondary stroke prevention in a child with SCD-SS proved fatal. Transcranial Doppler screening and exchange transfusion therapy are potentially life-saving interventions. Expanding access to these therapies across sub-Saharan Africa is an urgent priority.

Keywords: Anemia; sickle cell; Stroke; Malaria; Falciparum; Child; Africa South of the Sahara; Secondary prevention; Hemorrhagic transformation; Case report

Core Tip: This case highlights the fatal consequences of absent secondary stroke prevention in a child with sickle cell disease homozygous SS (SCD-SS). An 8-year-old girl who survived an initial ischemic stroke subsequently developed a fatal hemorrhagic stroke in the setting of Plasmodium falciparum malaria, without having received secondary preventive care. In sub-Saharan Africa, limited access to transcranial Doppler screening and exchange transfusion programs continues to place children with SCD-SS at high risk of recurrent cerebrovascular events. This report underscores the urgent need to strengthen early screening and secondary stroke prevention strategies in resource-limited settings.

Write to the Help Desk